But Botox remains a very important product for Allergan with therapeutic revenues of nearly $398 million in the first quarter alone, up 5.8% compared with last year’s Q1. Cosmetic revenues in Q1 ...

Mitchell Brin has a license plate that says "Botox." Brin's been researching Botox since 1984 and is currently the chief scientific officer of Botox at the drug company Allergan. It's one of many ...

Botox (onabotulinumtoxinA) is used in a variety of therapeutic indications as well as for cosmetic reasons and generated around $555 million for Allergan in its cosmetic and therapeutic uses in ...

Brent Saunders, the CEO of Allergan, the pharmaceutical company that makes Botox explains all of its current and projected uses. Follow TI: On Facebook More from Tech Botox is famous for treating ...

Merger deal, which values Allergan at around $160 billion, allows Pfizer to locate its tax base in Ireland ...